Expertise In Advancing Respiratory Disease Treatment

Therapeutic Depth:CNS

For millions who suffer from respiratory diseases, each breath can be a major accomplishment, whether the result of prematurity, chronic lung problems, heart attack, lung cancer or cystic fibrosis, another therapeutic area in which SynteractHCR specializes. With all types of lung disease combined, it is the number three killer in the United States.

We have strong relationships with clinical investigators and key opinion leaders worldwide to help you meet your respiratory trial goals. With our therapeutic and clinical expertise, we focus on your needs, and strategically customize services to deliver as promised at a competitive price, so you can make decisions quickly and move development forward at a rapid pace.

SynteractHCR respiratory expertise includes:

  • Allergic Rhinitis
  • Asthma
  • COPD
  • Chronic Bronchitis
  • Cystic Fibrosis
  • Emphysema
  • Idiopathic Pulmonary Fibrosis
  • Pneumothoraces associated with needle lung biopsies
  • Respiratory Distress Syndrome

Related Links

Well-rounded experience.

SynteractHCR has conducted
trials across all major
therapeutic areas and
we have contributed 
to more than 230
product approvals
since our
Learn More

Contact SynteractHCR

  • USA: +1 760 268 8200
  • Europe: +49 89 12 66 80 0
  • Contact Form...

Contact SynteractHCR

Tell us how to stay in touch with you:

Required Fields(*)